Recombinant Human B Cell Activating Factor Receptor
RP02284
Product Specifications
| Product Type | Recombinant protein |
|---|---|
| Applications | Bioactivity, Endotoxin |
| Source | E. coli. |
| UniProt No. | Q96RJ3;Q5H8V1; C8ZLJ6 |
| Purity | > 95 % by reduced SDS-PAGE analyses. |
| Bioactivity | Fully biologically active when compared to standard. The ED50 as determined by its ability to block BAFF induced mouse splenocyte survival is 1.0-5.0 μg/ml in the presence of 1.0 μg/ml of rHuBAFF. |
| Endotoxin | Less than 1 EU/μg of rHuBAFF-R as determined by LAL method. |
| Molecular Weight | Approximately 7.8 kDa, a single non-glycosylated polypeptide chain containing 76 amino acids. |
| Formulation | Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, pH 8.0, 500 mM NaCl. |
| Alternative Names | TNFRSF13C, BAFF Receptor, BAFF-R, BAFFR, BROMIX, CD268, CVID4, prolixin, Human |
| Storage | -20C |
| Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
| Research Area | Immunology |